Again in serum-free media, neutrophils degraded eightfold more elastin than macrophages but only macrophages degraded sepharose-coupled elastin in the presence of 10% serum. Because of these findings, we compared the enzymatic mechanisms of elastin breakdown by macrophages with that of neutrophils. Macrophage elastolytic activity is largely (65-80%) due to a cysteine proteinase(s), at least part of which is Cathepsin B. Approximately half of the cysteine proteinase activity appeared to be expressed at or near the cell surface.
Introduction
Elastin is a normal component of many tissues and is especially important to the normal architecture of lung. Destruction of lung elastin in experimental animals by purified elastase can reproduce the histological and mechanical features of emphysema (1) (2) (3) (4) (5) . Although alveolar macrophages are the major inflammatory cell in the histopathology of smoking individuals, neutrophils are currently considered the major source of elastase activity likely to lead to disruption of elastin and progressive emphysema. This hypothesis is based partly on the well known susceptibility of individuals, particularly smokers, with genetic deficiency in a,-antiproteinase to develop emphysema and the fact that a,-antiproteinase blocks neutrophil but not macrophage-derived elastase (6) . Moreover, studies of culture supernates and cell lysates of human alveolar macrophages indicate that most of the observed elastolytic activity can be explained by neutrophil elastase in the preparations (7) . Smoking individuals without genetic a,-antiproteinase deficiency are also at risk for emphysema. Recently reported data indicate that the alveolar surfaces of most such individuals may not be deficient in functionally active a,-antiproteinase which makes the susceptibility of these subjects to emphysema more difficult to explain (8) .
We recently observed that live human alveolar macrophages can degrade elastin if the cells contact the substrate (9) . In this study, we directly compare the elastolytic activities of live human neutrophils and alveolar macrophages co-cultured with a purified, insoluble 3H-elastin substrate. We find neutrophil elastolytic activity to be completely blocked by 1-10% human serum, whereas macrophage activity is inhibited only 20-40%. The difference in susceptibility of the two cells to macromolecular inhibitors is explained by fundamentally different degradative mechanisms. The findings suggest that in vivo, at sites of inflammation rich in proteinase inhibitors but where cells can contact substrate, e.g., elastin, macrophages degrade more matrix protein than neutrophils.
Methods
Cell preparation and cell culture. Healthy community volunteers underwent fiberoptic bronchoscopy as previously described (9) . Eight subjects were nonsmokers and seven subjects smoked at least one pack per day. The mean numbers of total cells±l SD in 100 ml of recovered alveolar lavage fluid from the nonsmoking and smoking groups were 11±4.3 and 60±37 million cells, respectively. Differential cell counting revealed mean values of 94 and 97% macrophages, 4.8 and 1.3% lymphocytes, and 0.5 and 1% neutrophils in the nonsmoking and smoking groups, respectively. The basic tissue culture medium used in all of the experiments in this study was Dulbecco's modified Eagle's medium (DMEM)' supplemented with 10 mM Hepes, streptomycin (100 Mg/ml), and penicillin (100 U/ml). The pooled cellular pellets were counted by hemocytometer and washed in DMEM. The cells were then immediately used for experiments.
Human neutrophils were purified from heparinized blood that was obtained from separate normal volunteers. Leukocyte-rich plasma was recovered after spontaneous erythrocyte sedimentation at 370C for 2 h. Neutrophils were then isolated by centrifugation over Ficoll-Hypaque (Pharmacia Fine Chemicals, Piscataway, NJ). The neutrophil preparations consisted of >95% neutrophils, <1% esterase-positive cells, and a few contaminating erythrocytes.
Preparations of alveolar fluid. Recovered alveolar fluid after bronchoalveolar lavage was dialyzed (3, 200 1 . Abbreviations used in this paper: DMSO, dimethyl sulfoxide; DMEM, Dulbecco's modified Eagle's medium; PMSF, phenylmethylsulfonylfluoride; Z-ala-arg-arg-AMC, benzyloxycarbonyl-alanyl-arginyl-arginyl4aminomethylcoumarin7-amide; Z-phe-ala-CHN2, benzyloxycarbonylphenylalanyl-alanyl-diazomethylketone; Z-phe-phe-CHN2, benzyloxycarbonyl-phenylalanyl-phenylalanyl-diazomethylketone; Z-phe-pro-CHN2, Z-phenylalanyl-prolyl-diazomethylketone.
Boston, MA) as described by Gordon et al. (10) . The radiolabeled elastin was washed until the washings contained <1% of the total radioactivity, were aliquoted, and stored at -70'C. Soluble bovine ligamentum elastin (Elastin Products, Inc.) was iodinated by a chloramine-T method (11) . The specific activity of the preparation was 1 X 104 cpm/ug protein. The '25I-elastin was then coupled to cyanogen bromide activated sepharose beads (Pharmacia Fine Chemicals). After extensive washing, the elastin-coated sepharose consisted of -6-7 Mg '25I-elastin per 5 Ml packed beads. The beads were rewashed before each experiment. Benzyloxycarbonyl-phenylalanyl-phenylalanyl-diazomethylketone (Z-phe-phe-CHN2 ), Z-phenylalanyl-propyl-diazomethylketone (Z-phe-pro-CHN2), benzyloxycarbonylphenylalanylalanyl-diazomethylketone (Z-phe-ala-CHN2), and benzyloxycarbonyl-alanyl-arginyl-arginyl-4aminomethylcoumarin7-amide (Z-ala-arg-arg-AMC) were obtained from Enzyme Systems Products (Torrence, CA) and dissolved in dimethyl sulfoxide (DMSO) at 1,000 times the highest concentration tested. Phenylmethylsulfonylfluoride (PMSF) (Sigma Chemical Co., St. Louis, MO) was also dissolved in DMSO at 1,000 times the highest concentration tested. All other reagents were of the highest grade commercially available.
Enzyme assays. Elastase activity was first assayed by solubilization of 3H-elastin (bovine ligamentum nuchae) in the absence of detergent as previously described (9 (13) . h incubation at 370C in DMEM with or without possible inhibitors of lysosomal enzymes, the cells were washed extensively to remove inhibitors. One million macrophages were then lysed in 200 Ml 88 mM KH2PO4-12 mM Na2HPO4 with 1.3 mM EDTA (pH 6.0) and 2.7 mM cysteine and 0.2% Triton X-100. Lysates were then diluted 1:25-1:100 in the same buffer without detergent. Z-alaarg-arg AMC, 0.1 mM final concentration, was used as substrate in a total reaction volume of 1 ml. After 60 min at 370C, enzyme activity was measured in arbitrary fluorescence units in a Perkin-Elmer spectrofluorometer. Preliminary data showed that fluorescence was proportional to enzyme concentration over the dilutions tested and that >95% of the fluorescence was blocked by preincubation of cellular lysates with the specific cysteine proteinase inhibitor, Z-phe-ala-CHN2
(10-5 M). Each experiment tested 1:25, 1:50, and 1:100 dilutions of the cell lysate and the cysteine proteinase nature of the fluorescence was routinely confirmed by adding I0-' M Z-phe-ala-CN2 to an aliquot of the reaction mixture.
Protein determination. Protein concentration was determined by the method of Lowry using a bovine albumin standard (14) . (o) cells per well, purified from blood, were assayed for elastolytic activity identically to macrophages. by live alveolar macrophages was dependent on the culture medium. Alveolar macrophages cultured in serum-free medium (DMEM) degraded a mean of 5.1 ug/106 cells per 24 h. These same cells, when cultured in 1% human serum, degraded 4.3 ,ug elastin (P < 0.01, paired t test, reference 15). The mean elastin degraded by cells from a larger group of 14 subjects (six smokers, eight nonsmokers) cultured in 1% human serum was 4.7 ,ug/24 h. Increasing the percentage unheated human serum from 1 to 10% did not further decrease elastin degradation in any of the subjects tested. As the data in Fig. 1 A also show, there was no difference in mean microgram elastin degraded on a per cell basis between smoking and nonsmoking individuals.
Data in Fig. 1 B show elastin degradation by blood neutrophils for comparison with macrophages. Neutrophils were cultured under identical conditions to that of macrophages and elastin degradation measured at both 4 and 24 h of culture. We made measurements at both 4 and 24 h because at 4 h, all cells were alive as judged by absence of trypan blue staining. At 24 h, most of the neutrophils, while intact, stained with trypan blue. Data in Fig. 1 B show the elastin degradation by 105 neutrophils per assay measured after 24 h culture. We show these data for comparison with alveolar macrophages because this cell number represents a higher proportion of neutrophils relative to 106 alveolar macrophages than was recovered by bronchoalveolar lavage from these smoking subjects or from smokers in previously reported data (16, 17) . Neutrophils cultured in DMEM hydrolyzed a mean of 19 sg elastin, whereas cells cultured in DMEM containing 1% human serum hydrolyzed <1 gg elastin. The ratio of elastin degraded by 106 alveolar macrophages to that of 10 neutrophils when both cells were cultured in 1% serum was approximately six. The data also show that 106 neutrophils degrade at least an order of magnitude more elastin than 106 macrophages in a 24-h assay. Again, neutrophil-mediated elastinolysis was very sensitive to human serum in the assay. Increasing the percentage of human serum supplementation to 10% totally blocked elastin degradation by either 105 or 106 neutrophils. Thus, in medium that contained 10% serum, only live macrophages measurably degraded elastin. Measurements of neutrophil degradation at 4 h showed proportionately less elastin solubilized, but the percentage inhibition by human serum was identical (not shown).
We considered the possibility that the relative resistance of macrophages to serum proteinase inhibitors was due to phagocytosis of particulate elastin by the larger macrophages. Therefore, we performed similar experiments with iodinated, soluble elastin that was covalently coupled to sepharose beads. The beads were too large to be phagocytized but were not toxic to the cells, as judged by cellular morphology and trypan blue staining. 5 gl of packed beads that contained 125I-elastin (6) (7) ug) were layered on top of 105 live alveolar macrophages or 105 neutrophils in microtiter chambers. Elastin degradation was again measured as solubilized radioactivity after 18-20 h (20, 21) .
A third distinction between neutrophil and macrophage elastolytic activity was indicated by the diazomethylketone, Zphe-ala-CN2. This specific cysteine proteinase inhibitor (22) had no effect on neutrophil elastin degradation but consistently inhibited 65-80% of intact macrophage elastin degradation. We also observed leupeptin (5 ,ug/ml) to similarly block macrophage but not neutrophil degradation in three experiments (not shown). The major cellular proteinase likely to be capable of elastin degradation as well as to be inhibitable by Z-phe-ala-CHN2 is the lysosomal proteinase, Cathepsin B. Recent studies show that rabbit and human alveolar macrophages contain a Cathepsin-B-like proteinase (23, 24) . We measured the effect of varying concentrations of the diazomethylketone on both cellular Cathepsin B as well as elastolytic activity. For these experiments, we used phe-phe instead of phe-ala diazomethylketone. This compound was comparable elastolytic inhibitory activity with phe-ala-CHN2 but was more available. Data in Fig. 2 show the effect of 1-10 MM Z-phephe-CHN2 on both Cathepsin B and elastolytic activities. We observed a dose-dependent increase in percent inhibition of We attempted to further distinguish between the neutrophil and macrophage elastolytic mechanisms by other classes of enzyme inhibitors. EDTA, a divalent cation chelator, did not distinguish the catalytic mechanisms. EDTA markedly inhibited live neutrophil activity (Table III) . However, EDTA did not inhibit the elastase activity of neutrophils lysed in 0.2% Triton X-l00 phosphate saline, pH 7.4 (not shown), which suggested that EDTA inhibits secretion of elastase by neutrophils and not the enzyme itself. Divalent cations are known to be critical to lysosomal enzyme secretion by neutrophils (25) . Although human monocyte-derived macrophages reportedly contain an elastase that is a metalloproteinase (26) , the observed effect of EDTA on live macrophage elastolytic activity may not be simply inhibition of a metalloproteinase. The chloromethylketone, succinyl-alanyl-alanyl-prolyl-valylchloromethylketone (Enzyme System Products) also did not distinguish the catalytic mechanisms. Although a known inhibitor of serine proteinases (27) , and totally blocking neutrophil elastolytic activity at 0.1 mM, this agent also inhibits cysteine proteinases (21). We observed 0.1-mM concentrations of the chloromethylketone to totally block intracellular Cathepsin B activity in experiments identical to those shown in Fig. 2 . Thus, the inhibitory effect of chloromethylketones can be explained by inhibition of the cysteine proteinase(s). The inhibition of neutrophil elastolytic activity by the chloromethylketone and PMSF, but not by the diazomethylketone, is consistent with previous reports that neutrophil elastases are serine proteinases (28, 29) .
We also attempted to combine inhibitors of separate enzyme classes, i.e., PMSF and diazomethylketone, but resultant toxicity to the cells as judged morphologically precluded interpretation of these experiments. The toxicity probably relates to the observation that concentrations of solvents used to solubilize these reagents, DMSOs, above 0.1% (vol/vol) suppressed elastolytic activity. Chloroquine, cytochalasin B, cycloheximide, and Z-phe-ala-CHN2 were added to DMEM that contained 1% human serum for macrophage assays and, in these cases, the activity of cells cultured in 1% serum alone was given a value of 100. 1% serum was added because the reagents were observed to be toxic to the macrophages in a 24-h assay in serum-free medium. Nevertheless, a similar pattern of inhibition was observed when macrophages were incubated in serum-free medium with Z-phe-ala-CN2, chloroquine, or cytochalasin B (not shown).
Discussion
Previous studies have defined the elastolytic activity of human neutrophils. These cells elaborate a serine proteinase active at neutral pH with marked elastinolytic capability. The enzyme has been purified and characterized (28, 29) . Moreover, Cathepsin G, also a serine proteinase, is released by neutrophils and cooperates with the elastase in elastin degradation (30 by macrophages from three subjects who were co-incubated with '251I-elastin coated sepharose beads (Table I) . Measurements at the cell surface of adherent macrophages indicate a pH of 5-6 which allow considerable cathepsin-like activity (31) . Overall, the data indicate that -35-45% of the elastin degradation by live alveolar macrophages occurs intracellularly and is mediated by a cysteine proteinase(s). Another 30-35% of total activity is mediated by this mechanism but occurs at the cell surface or in the immediate cellular microenvironment. The enzymatic mechanism of the remaining 20-25% of total degradation is unclear, but may be mediated by a metalloproteinase with elastolytic activity previously described in human alveolar macrophages (26) . Differences in the mechanisms of elastin breakdown by macrophages and neutrophils correlate with functional differences in elastinolysis by live cells. Data reported here and previously (9) indicate that live human alveolar macrophages can degrade elastin even in the presence of serum proteinase inhibitors. This is not because macrophage elastolytic enzymes are intrinsically resistant to serum proteinase inhibitors (32) . Rather, the close association of intact cells with substrate minimizes the effect of inhibitors. This appears to be particularly important for macrophage-mediated elastin degradation. Similar considerations apply to the resorption of bone matrix by osteoclasts and of extracellular matrix proteins by live murine peritoneal macrophages (33, 34) . Neutrophils, in contrast, at least as judged by their interaction with purified elastin, are dependent on secretion of soluble enzymes that are more easily inhibited by soluble proteinase inhibitors. This dependence on a soluble pathway of enzymatic degradation could reflect less intimate contact with the substrate by neutrophils as compared to macrophages. If so, this pattern of interaction is not peculiar to purified elastin. Neutrophil-mediated degradation of extracellular matrix elastin (smooth muscle cell derived) or of fibrin is equally sensitive to macromolecular inhibitors (Chapman, H. A., and C. L. Allen, unpublished observations). In addition, endothelial cell detachment by stimulated neutrophils, a protease-dependent process, also is reportedly very sensitive to soluble proteinase inhibitors (35, 36) . Our current studies, together with these previous observations, indicate that there are at least two major pathways of elastin degradation by human inflammatory cells: a neutrophil pathway involving released soluble elastases that are sensitive to serum and alveolar proteinase inhibitors; and macrophagemediated elastolysis that functions as a largely cell-associated pathway relatively resistant to serum and alveolar inhibitors. Although neutrophils have much higher elastolytic potential, under conditions of proteinase inhibitor excess, macrophages degrade more elastin than neutrophils (Fig. 1) . These observations may relate to connective tissue turnover at inflammatory sites. Direct analysis of proteinase inhibitor activity in human arthritic joints, for example, indicate an excess of inhibitors with little or no free proteolytic activity in the joint fluid (37, 38) . Similarly, recent measurements of proteinase inhibitor activity of alveolar lavage fluid of both nonsmoking and smoking subjects suggest an excess of inhibitors, including a,-antiproteinase at the alveolar surface (8) . Such Compared with nonsmokers, smoking subjects have a chronic macrophage bronchiolitis and alveolitis (41) . This likely results from increased trafficking of blood monocytes or monocyte precursors into the lung, where they differentiate in the alveolar interstitium to macrophages and migrate through the interstitium onto the alveolar surfaces. The exact signals for such an inflammatory response are not defined. Emphysema generally develops in a subpopulation of these smoking subjects. Our data do not show a clear difference in elastin degradation between smoking (0) and nonsmoking (0) subjects on a per cell basis (Fig. 1) . Rather, in that cellular movement is closely correlated with proteolytic activity (9, 42) , it is likely that the increased trafficking of macrophages through the lung results in accelerated degradation of elastin that is known to be in the interstitium (43) . The extent of injury could reflect in part the intensity and duration of the inflammatory response. However, we have not compared alveolar macrophages from smoking individuals with and without structural damage, i.e., emphysema. It remains possible that differences in elastolytic activity could exist between cells from these groups.
